FDA Approved: EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE — Supplemental Application (Cipla USA Inc.)

View source ↗

Summary

FDA approved Cipla USA Inc.'s supplemental application for a generic fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Emtricitabine and Tenofovir Disoproxil Fumarate (emtricitabine and tenofovir disoproxil fumarate)

Snippet

SUPPL AP for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)